Table 1.
Additional information concerning gender and age per nation and disease.
| Nation | BOR | BRU | CRY | LEP | PUU | QFE | TBE | TUL |
|---|---|---|---|---|---|---|---|---|
| Finland | 1995–2016 | 1995–2014 | 1995–2016 | 1995–2016 | 1995–2016 | 1998–2016 | 1995–2016 | 1995–2016 |
| Greenland | n/a | n/a | n/a | n/a | n/a | 2007–2007 * | n/a | n/a |
| Iceland | n/a | n/a | - | n/a | n/a | n/a | n/a | n/a |
| Norway | 1990–2016 | 2004–2016 | 2012–2016 | n/a | 1991–2016 | n/a | 1998–2016 | 1985–2016 |
| Russia | - | - | n/a | - | - | - | - | - |
| Sweden | - | - | 2004–2016 | - | 1985–2016 | - | 1978–2016 | 1969–2016 |
n/a (not applicable) indicates that the disease has not been reported. (-) indicates a lack of supplementary information despite reported diseases. Ixodid tick-borne borrelioses (BOR); brucellosis (BRU); cryptosporidiosis (CRY); leptospiroses (LEP); hemorrhagic fever with renal syndrome/Puumala virus infection (PUU); Q fever (QFE); tick-borne encephalitis (TBE); tularemia (TUL). * = A single case of QFE reported in Greenland 2007.